» Articles » PMID: 8947921

Sigma Binding in a Human Neuroblastoma Cell Line

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 1996 Nov 1
PMID 8947921
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Behaviorally, sigma1 agents modulate opioid analgesia. To examine possible mechanisms responsible for these interactions, we have identified a cell line containing both sigma1 and opioid receptors. [3H](+)-pentazocine binding in BE(2)-C human neuroblastoma cells is high affinity (KD 3.4 +/- 0.7 nM) and high density (Bmax 2.98 +/- 0.14 pmol/mg protein). Competition studies reveal a selectivity profile similar to that of sigma1 sites in guinea pig brain. (+)-Pentazocine has no effect upon either basal or forskolin-stimulated cyclase in the BE(2)-C cells, but cAMP accumulation is inhibited by the morphine, DPDPE and naloxone benzoylhydrazone. (+)-Pentazocine at concentrations as high as 10 microM does not affect this opioid effect, implying that sigma1/opioid interactions are not mediated at the level of the cell. This suggest that their behavioral interactions result from interacting neural circuits. Although (+)-pentazocine is without effect in the cyclase system, it does block carbachol-stimulated phosphoinositol turnover (IC50 6.5 +/- 1.14 microM). The specificity of the effect is confirmed by the ability of haloperidol (1 microM) to shift the IC50 value of (+)-pentazocine 2-fold to the right.

Citing Articles

Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using ()-(-)-[F]Fluspidine in Glioblastoma.

Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig F, Juratli T Molecules. 2020; 25(9).

PMID: 32384802 PMC: 7248975. DOI: 10.3390/molecules25092170.


Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.

Oyer H, Sanders C, Kim F Front Pharmacol. 2019; 10:1141.

PMID: 31695608 PMC: 6816035. DOI: 10.3389/fphar.2019.01141.


Isolation and characterization of alternatively spliced variants of the mouse sigma1 receptor gene, Sigmar1.

Pan L, Pasternak D, Xu J, Xu M, Lu Z, Pasternak G PLoS One. 2017; 12(3):e0174694.

PMID: 28350844 PMC: 5370144. DOI: 10.1371/journal.pone.0174694.


Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

Thomas J, Longen C, Oyer H, Chen N, Maher C, Salvino J Cancer Res. 2017; 77(9):2439-2452.

PMID: 28235766 PMC: 5462524. DOI: 10.1158/0008-5472.CAN-16-1055.


Sigma receptors [σRs]: biology in normal and diseased states.

Rousseaux C, Greene S J Recept Signal Transduct Res. 2015; 36(4):327-388.

PMID: 26056947 PMC: 4906365. DOI: 10.3109/10799893.2015.1015737.


References
1.
Weiland G, Molinoff P . Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981; 29(4):313-30. DOI: 10.1016/0024-3205(81)90324-6. View

2.
Costa E, Hoffmann B, Loew G . Opioid agonists binding and responses in SH-SY5Y cells. Life Sci. 1992; 50(1):73-81. DOI: 10.1016/0024-3205(92)90199-y. View

3.
Blume A, Lichtshtein D, Boone G . Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP. Proc Natl Acad Sci U S A. 1979; 76(11):5626-30. PMC: 411702. DOI: 10.1073/pnas.76.11.5626. View

4.
Bowen W, Hellewell S, McGarry K . Evidence for a multi-site model of the rat brain sigma receptor. Eur J Pharmacol. 1989; 163(2-3):309-18. DOI: 10.1016/0014-2999(89)90200-8. View

5.
Vilner B, Bowen W . Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture. Eur J Pharmacol. 1993; 244(2):199-201. DOI: 10.1016/0922-4106(93)90029-9. View